Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -26,953 | 19,047 | 15,597 | 9,989 |
| Depreciation Amortization | 68,256 | 10,774 | 12,921 | 15,307 |
| Income taxes - deferred | -593 | -1,754 | 483 | 6,297 |
| Accounts receivable | -4,417 | -3,776 | -4,993 | -1,885 |
| Other Working Capital | 969 | -11,080 | 6,574 | 5,759 |
| Other Operating Activity | -9,824 | -13,477 | -9,471 | -6,053 |
| Operating Cash Flow | $27,438 | $-266 | $21,111 | $29,414 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -169,376 | -200,428 | -123,005 | -113,142 |
| Net Acquisitions | -14,566 | N/A | N/A | N/A |
| Sale Of Investment | 99,773 | 113,402 | 117,164 | 102,097 |
| Other Investing Activity | 6,563 | 3,991 | 3,753 | 2,817 |
| Investing Cash Flow | $-77,606 | $-83,035 | $-2,088 | $-8,228 |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 134,600 | 138,100 | 188,890 | 82,472 |
| Debt Issued | 2,944 | N/A | N/A | N/A |
| Debt Repayment | -3,308 | -38,025 | -16,825 | -16,825 |
| Common Stock Issued | 10,767 | 78,117 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -40,104 | N/A |
| Dividend Paid | N/A | -804 | N/A | N/A |
| Other Financing Activity | -74,340 | -106,019 | -138,337 | -84,689 |
| Financing Cash Flow | $70,663 | $71,369 | $-6,376 | $-19,042 |
| Exchange Rate Effect | -393 | 6 | 139 | -103 |
| Beginning Cash Position | 8,433 | 20,359 | 11,842 | 5,532 |
| End Cash Position | 28,535 | 8,433 | 24,628 | 7,573 |
| Net Cash Flow | $20,102 | $-11,926 | $12,786 | $2,041 |
| Free Cash Flow | ||||
| Operating Cash Flow | 27,438 | -266 | 21,111 | 29,414 |
| Capital Expenditure | -189,733 | -219,666 | -135,338 | -127,638 |
| Free Cash Flow | -162,295 | -219,932 | -114,227 | -98,224 |